Picture Berlin Partner Hotspot for Startups 650x80px

Organisation › Details

United Kingdom (GB) (govt)

https://www.direct.gov.uk


	Region	London, Greater London
	Country	United Kingdom (GB)
	City	n. a. London
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2021-04-09

Picture [iito] Made Without Love 650x80px

More documents for United Kingdom (GB) (govt)

[1] Valneva S.E.. (4/6/21). "Press Release: Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001". Saint-Herblain....
[2] Alchemab Therapeutics Ltd.. (3/16/21). "Press Release: Alchemab and Medicines Discovery Catapult to Develop Landmark Novel Antibody Therapy for Huntington’s disease". London....
[3] Pathios Therapeutics Ltd.. (3/8/21). "Press Release: Pathios Therapeutics Boosted by Award of Significant Innovate UK Funding". Oxford....
[4] Rentschler Biopharma SE. (2/11/21). "Press Release: Rentschler Biopharma Establishes Center of Excellence for Cell and Gene Therapy in the UK". Laupheim & Stevenage....
[5] Rentschler Biopharma SE. (2/11/21). "Press Release: Rentschler Biopharma to Build New Cell and Gene Therapy Capabilities in the UK". London & Laupheim....
[6] NovaBiotics Ltd.. (10/16/20). "Press Release: NovaBiotics Secures £1 Million in Funding from Innovate UK to Support Clinical Development of Nylexa for COVID-19". Aberdeen....
[7] Medicines Discovery Catapult, The. (9/23/20). "Press Release: Innovate UK Funding for New Precision Cancer Treatment Technology. Sixfold Bioscience and Medicines Discovery Catapult Awarded Innovate UK Grant to Pursue Ground-breaking Project"....
[8] Valneva S.E.. (7/20/20). "Press Release: Valneva Confirms Participation in UK Government COVID-19 Vaccine Response Program". Saint-Herblain....
[9] BioNTech SE. (7/20/20). "Press Release: Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz....
[10] Epidarex Capital. (6/22/20). "Press Release: Epidarex Capital Closes New £102 Million UK Venture Fund to Build Successful Life Science Companies". Edinburgh....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]